Latest bladder cancer Stories
DALLAS, March 26, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" to
An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March
An increased risk of bladder cancer may not be the only disease risk for people treated with the diabetes drug Actos. Raleigh, NC (PRWEB) March 21, 2014
For the first time, scientists have succeeded in coaxing laboratory cultures of human stem cells to develop into the specialized, unique cells needed to repair a patient’s defective or diseased
Researchers say resveratrol slows cancer growth without the toxicity and irritation of chemotherapy. Raleigh, NC (PRWEB) March 16, 2014 A new report
Indian researchers say a simple urine test could offer a less invasive diagnostic solution for early stage bladder cancer. Raleigh, NC (PRWEB) March 14, 2014
A new study published in the British Journal of Clinical Pharmacology, recommends prescribers limit pioglitazone (Actos) use to shorter durations due to significantly increased risk of bladder
Another meta-analysis has confirmed an increased risk of bladder cancer among diabetes patients who have taken the drug Actos (pioglitazone). Raleigh, NC (PRWEB)
National network of attorneys continues to provide no-cost consultations over allegations that the use of the diabetes medication Actos can cause bladder cancer. San
Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.